Candriam S.C.A. Mei Pharma, Inc. Transaction History

Candriam S.C.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 21, 2020	SELL	$1.65 - $2.48 $247,500 - $372,000	-150,000 Closed	0 $0
Q3 2019 Oct 21, 2019	SELL	$1.48 - $2.52 $532,800 - $907,200	-360,000 Reduced 70.59%	150,000 $0
Q4 2018 Feb 14, 2019	BUY	$1.92 - $4.1 $163,200 - $348,499	85,000 Added 20.0%	510,000 $1.35 Million
Q3 2018 Nov 07, 2018	BUY	$3.39 - $4.61 $1.44 Million - $1.96 Million	425,000 New	425,000 $1.83 Million

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $397M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.